1st Quarter - Report

NATIONAL KIDNEY FOUNDATION for NATIONAL KIDNEY FOUNDATION

Firm
Client
Income
—
Expenses
$120,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Early detection and management of Chronic Kidney Disease, including Alternative Payment Model Increased utilization of home dialysis Extension of Medicare coverage of immunosuppressive drugs for kidney transplant recipients Increased use of Kidney Discards for transplantation Access of medications under Medicare Part D Protected Classes Medicare Advantage Step Therapy Modification of ICD-10-CM Codes

LobbyistCovered position, as disclosed
ANDREW W. FULLERTON —
TONYA SAFFER —
TROY ZIMMERMAN —

Contacted: HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Health Resources & Services Administration (HRSA); Natl Institutes of Health (NIH); Centers For Disease Control & Prevention (CDC); SENATE; Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS)

Health Issues HCR

Initiatives to increase and facilitate organ donation and transplantation, including the Living Donor Protection Act (S. 511 / H.R. 1224); funding for the National Living Donor Assistance Center; increased utilization of Kidney Discards Early detection and management of Chronic Kidney Disease Department of Health and Human Services Million Hearts initiative Department of Health and Human Services KidneyX initiative Prescription Drug Pricing and Access Comments on Healthy People 2030 Management of the Patient Protection and Affordable Care Act Reauthorization of the Patient-Centered Outcomes Research Institute Repeal and Replacement of the Affordable Care Act

LobbyistCovered position, as disclosed
ANDREW W. FULLERTON —
TONYA SAFFER —
TROY ZIMMERMAN —

Contacted: Health Resources & Services Administration (HRSA); Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); SENATE; Health & Human Services, Dept of (HHS); Centers For Disease Control & Prevention (CDC)

Bills named: S. 511 (116th), H.R. 1224 (116th)

Budget/Appropriations BUD

FY 2019 and FY 2020 Appropriations for the Department of Health and Human Services (NIH, CDC, HRSA); Food and Drug Administration; Indian Health Service, Veterans Affairs, and Department of Defense

LobbyistCovered position, as disclosed
TONYA SAFFER —
TROY ZIMMERMAN —

Contacted: Health & Human Services, Dept of (HHS); Health Resources & Services Administration (HRSA); Centers For Medicare and Medicaid Services (CMS); Centers For Disease Control & Prevention (CDC); Natl Institutes of Health (NIH); HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.